Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 18, 2008, Pages 6690-6695

  Xu, Hui ^a   Oriss, Timothy B ^a   Fei, Mingjian ^a   Henry, Adam C ^a   Melgert, Barbro N ^b   Chen, Li ^a   Mellor, Andrew L ^c   Munn, David H ^c   Irvin, Charles G ^d   Ray, Prabir ^a   Ray, Anuradha ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Airways; Asthma; DC; Tryptophan

Indexed keywords

IMMUNOGLOBULIN E; INDOLEAMINE 2,3 DIOXYGENASE; ANTIGEN; CYTOKINE; EPITOPE;

ALLERGY; ANIMAL CELL; ARTICLE; ASTHMA; BONE MARROW CELL; BRONCHUS HYPERREACTIVITY; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; MUCUS SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; CHRONIC DISEASE; CROSS PRESENTATION; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; LUNG; LYMPH NODE; LYMPHOCYTE ACTIVATION; PATHOLOGY; PATHOPHYSIOLOGY;

MUS;

ANIMALS; ANTIGENS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CELL PROLIFERATION; CHRONIC DISEASE; CROSS-PRIMING; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITOPES; HYPERSENSITIVITY; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; LUNG; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; TH2 CELLS;

EID: 44349184791     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0708809105     Document Type: Article

References (39)

1. Mellor AL, et al. (2003) Tryptophan catabolism and T cell responses. Adv Exp Med Biol 527:27-35.
2. Mellor AL, Munn DH (2004) IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol 4:762-774.
3. Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1:609-620.
4. Beutelspacher SC, et al. (2006) Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am J Transplant 6:1320-1330.
5. Odemuyiwa SO, et al. (2004) Cutting edge: Human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 173:5909-5913.
6. Munn DH, Mellor AL (2004) IDO and tolerance to tumors. Trends Mol Med 10:15-18.
7. Uyttenhove C, et al. (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-1274.
8. Fallarino F, et al. (2002) Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. Int Immunol 14:65-68.
9. Orabona C, et al. (2005) Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood 107:2846-2854.
10. Mellor A (2005) Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem Biophys Res Commun 338:20-24.
11. Munn DH (2006) Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation. Curr Opin Immunol 18:220-225.
12. Kwidzinski E, et al. (2005) Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 19:1347-1349.
13. Terness P, Chuang JJ, Opelz G (2006) The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol 27:68-73.
14. Platten M, et al. (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310:850-855.
15. Swanson KA, Zheng Y, Heidler KM, Mizobuchi T, Wilkes DS (2004) CDIIc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30:311-318.
16. Munn DH, Mellor AL (2007) Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147-1154.
17. McMenamin C, Pimm C, McKersey M, and Holt PG (1994) Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells. Science 265:1869-1871.
18. Ostroukhova M, et al. (2004) Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest 114:28-38.
19. Ostroukhova M, et al. (2006) Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. J Clin Invest 116:996-1004.
20. Huh JC, et al. (2003) Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med 198:19-30.
21. Das J, et al. (2001) A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat Immunol 2:45-50.
22. Zhang DH, et al. (1999) Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11:473-482.
23. Carroll NG, Mutavdzic S, and James AL (2002) Increased mast cells and neutrophils in submucosal glands and mucus plugging in patients with asthma. Thorax 57:677-682.
24. de Marco R, et al. (2006) Prognostic factors of asthma severity: A 9-year international prospective cohort study. J Allergy Clin Immunol 117:1249-1256.
25. Oriss TB, et al. (2005) Dynamics of dendritic cell phenotype and interactions with CD4+ T cells in airway inflammation and tolerance. J Immunol 174:854-863.
26. Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA (2001) Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 193:51-60.
27. Stumbles PA, et al. (1998) Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 188:2019-2031.
28. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476.
29. Chen X, et al. (2006) Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation. Immunol Lett 107:140-147.
30. Hayashi T, et al. (2004) Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 114:270-279.
31. Grohmann U, et al. (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13:579-586
32. Hayashi T, et al. (2007) 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci USA 104:18619-18624.
33. Christen S, Peterhans E, Stocker R (1990) Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci USA 87:2506-2510.
34. Snapper CM, Paul WE (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
35. Baban B, et al. (2004) Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 61:67-77.
36. Xu H, Williams MS, Spain LM (2006) Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells. Blood 107:2400-2408.
37. Irvin CG, Bates JH (2003) Measuring the lung function in the mouse: the challenge of size. Respir Res 4:4.
38. Bates JH, Irvin CG (2003) Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 94:1297-1306.
39. Chen L, et al. (2006) Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide. J Immunol 177:2373-2383.